New Technologies in Diagnostics of Dry Eye Syndrome: Prospects of Use

Authors

  • Jalalova Dilfuza Zuhridinovna Department of Ophthalmology, Samarkand State Medical University
  • Yaxshinorov Islom Samarkand State Medical University, Department of Ophthalmology, 1st year clinical ordinator

Keywords:

Types of corneal-conjunctival xerosis, Signs and symptoms of the disease, Classification of dry eye syndrome by causes

Abstract

Dry eye syndrome (DES, corneal-conjunctival xerosis) is an inflammatory damage to the cornea and conjunctiva caused by a decrease in the amount of tears and a change in their chemical composition. The disease is typical for residents of developed countries - the prevalence of pathology among Russians is 15-17%. Most often these are adults, but among the patients there are also children and adolescents. The proportion of diseases increases with age - among men and women under the age of 40, dry eye syndrome is detected in 12% of people, after the age of 50 - in 60%. The disease not only causes discomfort, but also increases the risk of developing infectious inflammation of the eye and contributes to a decrease in vision. In this article, we will talk about the causes, symptoms and treatment of dry eye syndrome.

References

Yanchenko SV, Malyshev AV, Odilova GR, Petrosyan LM, Odilov M.Yu. New options for the treatment of hyposecretory dry eye syndrome // Ophthalmology, No. 20 (3) - 2023. Source: ophthalmojournal.com

Maychuk D.Yu., Loskareva AO Features of treatment of patients with dry eye syndrome, including corneal epithelization disorders // Ophthalmology, No. 16 (4) - 2019. Source: ophthalmojournal.com

Долиев, М. Н., Тулакова, Г. Э., Кадырова, А. М., Юсупов, З. А., & Жалалова, Д. З. (2016). Эффективность комбинированного лечения пациентов с центральной серозной хориоретинопатией. Вестник Башкирского государственного медицинского университета, (2), 64-66.

Zukhridinovna, Z. D. (2022). Modern aspects of neuroprotective treatment in hypertensive retinopathy.

Jalalova, D., Raxmonov, X., & Shernazarov, F. (2022). THE ROLE OF C-REACTIVE PROTEIN IN THE PATHOGENESIS OF VISUAL VASCULAR DISEASES IN PATIENTS WITH ARTERIAL HYPERTENSION. Science and Innovation, 1(8), 114-121.

Jalalova, D., Raxmonov, X., & Shernazarov, F. (2022). SIGNIFICANCE OF ENDOTHELIAL DYSFUNCTION IN THE DEVELOPMENT OF RETINOPATHY IN PATIENTS WITH AH AND WAYS OF ITS CORRECTION. Science and Innovation, 1(8), 101-113.

Jalalova, D., Axmedov, A., Kuryazov, A., & Shernazarov, F. (2022). COMBINED DENTAL AND EYE PATHOLOGY. Science and innovation, 1(8), 91-100.

Саттарова, Х. С., Жалалова, Д. З., & Бектурдиев, Ш. С. (2011). Причины слепоты и слабовидения при сахарном диабете. Академический журнал Западной Сибири, (6), 27-28.

Arunachalam, S. (2008). The science race continues in Asia. Current Science (00113891), 94(7).

Zukhriddinovna, Z. D. (2022). Development of Classification Criteria for Neuroretinal Ischemia in Arterial Hypertension. Central Asian Journal of Medical and Natural Science, 3(3), 59-65.

Жалалова, Д. З., & Исмоилов, Ж. Ж. (2024). ТЕОРЕТИЧЕСКОЕ ОБОСНОВАНИЕ ИССЛЕДОВАНИЯ ЭНДОТЕЛИНА-1 И Д-ДИМЕРОВ В КРОВИ И СЛЕЗНОЙ ЖИДКОСТИ ПАЦИЕНТОВ С ГИПЕРТОНИЧЕСКОЙ АНГИОРЕТИНОПАТИЕЙ. AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI, 3(3), 294-299.

Киселева, Т. Н., Ежов, М. В., Аджемян, Н. А., Танковский, В. Э., & Ильина, Н. В. (2016). Особенности регионарного глазного кровотока при артериальной гипертензии I-II степени и субклиническом атеросклерозе. Российский офтальмологический журнал, 9(3), 26-33.

Жалалова, Д. З., Кадирова, А. М., & Хамракулов, С. Б. (2021). Исходы герпетических кератоувеитов на фоне лечения препаратом «офтальмоферон» в зависимости от иммунного статуса пациентов. междисциплинарный подход по заболеваниям органов головы и шеи, 103.

Дроздова, Е. А., & Хохлова, Д. Ю. (2015). Морфометрическая характеристика макулярной зоны у пациентов с окклюзией вен сетчаткипо данным оптической когерентной томографии. Медицинский вестник Башкортостана, 10(2 (56)), 64-67.

Jalalova, D., Axmedov, A., Kuryazov, A., & Shernazarov, F. (2022). СОЧЕТАННАЯ СТОМАТОЛОГИЧЕСКАЯ И ГЛАЗНАЯ ПАТОЛОГИЯ. Science and innovation, 1(D8), 91-100.

Zhang, S., & Melander, S. (2014). Varicose veins: Diagnosis, management, and treatment. The Journal for Nurse Practitioners, 10(6), 417-424.

Жалалова, Д. З., & Бабаев, С. А. (2024). РЕЗУЛЬТАТЫ ОЦЕНКИ УРОВНЯ ЭНДОТЕЛИНА-1 И Д-ДИМЕРОВ В СЛЕЗНОЙ ЖИДКОСТИ У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ. AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI, 3(3), 300-307.

Zukhriddinovna, Z. D. (2022). Development of Classification Criteria for Neuroretinal Ischemia in Arterial Hypertension. Central Asian Journal of Medical and Natural Science, 3(3), 59-65.

Tatarnikova EB, Krivosheina OI Dry eye syndrome: modern aspects of etiology and pathogenesis // Breast cancer. Clinical Ophthalmology, Volume 20, No. 3 - 2020. Source: cyberleninka.ru

Loskutov IA, Korneeva AV Diagnosis and treatment of dry eye syndrome in outpatient settings // Effective Pharmacotherapy, Volume 15, No. 33 - 2019. Source: elibrary.ru

Brjesky VV, Popov V.Yu., Kalinina NM, Brjeskaya IV Prevention and treatment of degenerative changes in the ocular surface epithelium in dry eye syndrome // Bulletin of Ophthalmology, Volume 134, No. 5 - 2018. Source: elibrary. ru

Published

2024-11-16

How to Cite

Jalalova Dilfuza Zuhridinovna, & Yaxshinorov Islom. (2024). New Technologies in Diagnostics of Dry Eye Syndrome: Prospects of Use. International Journal of Alternative and Contemporary Therapy, 2(11), 36–41. Retrieved from http://medicaljournals.eu/index.php/IJACT/article/view/1170